{{Rsnum
|rsid=2930291
|Gene=CCDC33
|Chromosome=15
|position=74312493
|Orientation=minus
|GMAF=0.461
|Gene_s=CCDC33
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 37.5 | 51.8 | 10.7
| HCB | 8.0 | 36.5 | 55.5
| JPT | 6.2 | 38.9 | 54.9
| YRI | 8.8 | 40.8 | 50.3
| ASW | 12.3 | 50.9 | 36.8
| CHB | 8.0 | 36.5 | 55.5
| CHD | 5.5 | 41.3 | 53.2
| GIH | 18.8 | 42.6 | 38.6
| LWK | 15.5 | 46.4 | 38.2
| MEX | 29.3 | 43.1 | 27.6
| MKK | 5.8 | 37.8 | 56.4
| TSI | 33.3 | 45.1 | 21.6
| HapMapRevision=28
}}[[rs2930291]] has been reported in a large study to be associated with [[type-2 diabetes]].

The risk allele (oriented to the dbSNP entry) is (C); the odds ratio associated with heterozygotes is 1.25 (CI 1.04-1.51), and for homozygotes, 1.50 (CI 1.24-1.82). {{PMID|17554300|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}